Pharmacotherapy and related guidelines.

Victorian Pharmacotherapy policy

Policy for maintenance pharmacotherapy for opioid dependence (2016)

Overarching policy for delivering medication assisted treatment for opioid dependence in Victoria.

Buprenorphine with naloxone (Suboxone)

Medical practitioners may now prescribe buprenorphine/naloxone (Suboxone┬«) for up to five patients without the need to attend the one-day Pharmacotherapy GP Training Program. Medical practitioners may refer to the following guide for advice on the key regulatory and policy requirements for prescribing buprenorphine/naloxone.  An online video, produced by Networking Health Victoria, is also available.

A brief guide to prescribing buprenorphine/naloxone

(pdf) A guide for medical practitioners prescribing buprenorphine/naloxone under the five-patient-limit rules.

Buprenorphine/Naloxone - safer prescribing

(RACGP video - approx. 15 mins)

National clinical guidelines

National Guidelines for Medicated Assisted Treatment of Opioid Dependence 2014

Commonwealth Department of Health, April 2014


The Royal Australian College of General Practitioners provides online and face-to-face pharmacotherapy training for General Practitioners in two parts: Module 1 and Module 2. The online learning module, Safer Opioid Prescribing, is a pre-requisite for attending the one-day Pharmacotherapy GP Training Program, Module 2.

This training is supported via the hapn network through promotion, on-the-day attendance and a follow-up program, including by linking delegates with experienced prescribers for advice and mentoring, when required.

Learn more about training opportunities or book now at the RACGP learbing portal.


All links provided are direct links to the Victorian Department of Health original documents unless specified. A list of all Department pharmacotherapy forms can be found here.